Biotech · Private company
Helsinn Healthcare SA
Track this companyFree. Adds Helsinn Healthcare SA to your Dealase workspace and tells you when its record changes.
Clinical trials150 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- anamorelin HClPhase 3 · Cachexia; CancerClinicalTrials.gov · fetched Nov 12, 2026
- Anamorelin HydrochloridePhase 3 · Cachexia; CancerClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 3 · Chemotherapy-Induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- fosnetupitant/ palonosetronPhase 3 · Chemotherapy-induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- I.V. palonosetronPhase 3 · Chemotherapy-Induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- netupitant/palonosetronPhase 3 · Chemotherapy-induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- Oral palonosetronPhase 3 · Chemotherapy-Induced Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- PracinostatPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 2 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- InfigratinibPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- NetupitantPhase 2 · Chemotherapy-induced Nausea and Vomiting (CINV)ClinicalTrials.gov · fetched Nov 12, 2026
- PalonosetronPhase 2 · Chemotherapy-induced Nausea and Vomiting (CINV)ClinicalTrials.gov · fetched Nov 12, 2026
- PracinostatPhase 2 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic ChemotherapyPHASE2 · UNKNOWN · started Sep 9, 2023ClinicalTrials.gov NCT06065722 · fetched Nov 12, 2026
- Anamorelin Study for Advanced Pancreatic CancerPHASE2 · TERMINATED · started Apr 1, 2023ClinicalTrials.gov NCT04844970 · fetched Nov 12, 2026
- Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 AlterationsPHASE1_PHASE2 · WITHDRAWN · started Oct 1, 2021ClinicalTrials.gov NCT05222165 · fetched Nov 12, 2026
- Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic AlterationsPHASE3 · TERMINATED · started Mar 11, 2020ClinicalTrials.gov NCT04197986 · fetched Nov 12, 2026
- Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/TranslocationsPHASE3 · TERMINATED · started Dec 27, 2019ClinicalTrials.gov NCT03773302 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 2PHASE3 · COMPLETED · started May 6, 2019ClinicalTrials.gov NCT03743064 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1PHASE3 · COMPLETED · started Mar 5, 2019ClinicalTrials.gov NCT03743051 · fetched Nov 12, 2026
- A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast CancerPHASE3 · COMPLETED · started Mar 16, 2018ClinicalTrials.gov NCT03403712 · fetched Nov 12, 2026
- PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and VomitingPHASE2 · COMPLETED · started Aug 31, 2017ClinicalTrials.gov NCT03204279 · fetched Nov 12, 2026
- An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid LeukemiaPHASE3 · TERMINATED · started Jun 23, 2017ClinicalTrials.gov NCT03151408 · fetched Nov 12, 2026
- A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic SyndromesPHASE2 · TERMINATED · started Jun 1, 2017ClinicalTrials.gov NCT03151304 · fetched Nov 12, 2026
- Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With CancerPHASE2_PHASE3 · COMPLETED · started May 3, 2017ClinicalTrials.gov NCT03040726 · fetched Nov 12, 2026
- A Phase II, Single Arm Study of BGJ398 in Patients With Advanced CholangiocarcinomaPHASE2 · TERMINATED · started Jul 23, 2014ClinicalTrials.gov NCT02150967 · fetched Nov 12, 2026
- Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)PHASE2 · COMPLETED · started Dec 24, 2013ClinicalTrials.gov NCT01912274 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and VomitingPHASE3 · COMPLETED · started Jul 1, 2011ClinicalTrials.gov NCT01363479 · fetched Nov 12, 2026